The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The genomic landscape and its prognostic significance for stage III colorectal cancer in Japan: An ancillary study of JCOG0910 trial—JCOG1506A1.
 
Dai Shida
No Relationships to Disclose
 
Aya Kuchiba
Honoraria - Chugai Pharma
 
Tatsuhiro Shibata
No Relationships to Disclose
 
Tetsuya Hamaguchi
Honoraria - Bayer; Bristol-Myers Squibb Japan; Chugai Pharma; Lilly; Merck Serono; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Consulting or Advisory Role - NanoCarrier
Research Funding - Chugai Pharma (Inst); Dainippon Sumitomo Pharma (Inst); Kobayashi Pharmaceutical (Inst); Merck Serono (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Satoshi Yamasaki
No Relationships to Disclose
 
Masaaki Ito
No Relationships to Disclose
 
Takaya Kobatake
No Relationships to Disclose
 
Nobuhiro Takiguchi
No Relationships to Disclose
 
Tadahiko Masaki
No Relationships to Disclose
 
Manabu Shiozawa
No Relationships to Disclose
 
Yasumasa Takii
No Relationships to Disclose
 
Hiroyuki Uetake
No Relationships to Disclose
 
Shu Okamura
No Relationships to Disclose
 
Hitoshi Ojima
No Relationships to Disclose
 
Yusuke Nishizawa
No Relationships to Disclose
 
Hiroshi Takeyama
No Relationships to Disclose
 
Keisuke Kanato
No Relationships to Disclose
 
Yasuhiro Shimada
Honoraria - AstraZeneca; Bayer Yakuhin; Chugai Pharma; Daiichi Sankyo; Lilly Japan; Merck Serono; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical; TAKEDA; Tsumura & Co.; Yakult Honsha
Research Funding - Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Lilly Japan (Inst); Merck Serono (Inst); MSD K.K (Inst); Taiho Pharmaceutical (Inst)
 
Yoshinori Murakami
No Relationships to Disclose
 
Yukihide Kanemitsu
No Relationships to Disclose